CLINICAL_TRIALS
trial_result
· 2019-12-09
Clinical Trial Update: Open-label Study of the Efficacy of Intranasal Oxytocin in Schizophrenia [NA]
Summary
Open-label study investigating intranasal oxytocin for schizophrenia has terminated; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of California, San Diego | Conditions: Schizophrenia | NA | Status: TERMINATED | Results posted: 2019-12-09